CG Oncology CGON Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about CG Oncology's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is CG Oncology's net change in cash?
- CG Oncology (CGON) reported net change in cash of $1.21M in Q1 2026.
- How has CG Oncology's net change in cash changed year-over-year?
- CG Oncology's net change in cash increased by 100.6% year-over-year, from -$215.6M to $1.21M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.